The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

David Yates Graham

Department of Medicine

Michael E. DeBakey Veterans Affairs Medical Center and Baylor College of Medicine

Houston

Texas

USA

[email]@bcm.tmc.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Medicine, Michael E. DeBakey Veterans Affairs Medical Center and Baylor College of Medicine, Houston, Texas, USA. 1997 - 2012
  • VAMC and Baylor College of Medicine, Houston, TX 77030, usa. 2006
  • Department of Medicine, VA Medical Center, Room 3A-320 (111D), 2002 Holcombe Boulevard, USA. 2005
  • The VA Medical Center, Houston, Texas 77030, USA. 2000 - 2004
  • Departments of Medicine, Paediatrics, Pathology, Molecular Virology and Microbiology, USA. 2000

References

  1. Letter: the ethics of using inferior regimens in H. pylori randomised trials. Graham, D.Y., Fischbach, L.A. Aliment. Pharmacol. Ther. (2012) [Pubmed]
  2. Understanding and appreciating sequential therapy for Helicobacter pylori eradication. Graham, D.Y., Rimbara, E. J. Clin. Gastroenterol. (2011) [Pubmed]
  3. Clinical practice: diagnosis and evaluation of dyspepsia. Graham, D.Y., Rugge, M. J. Clin. Gastroenterol. (2010) [Pubmed]
  4. Eradication of gastric cancer and more efficient gastric cancer surveillance in Japan: two peas in a pod. Graham, D.Y., Asaka, M. J. Gastroenterol. (2010) [Pubmed]
  5. Helicobacter pylori treatment in the era of increasing antibiotic resistance. Graham, D.Y., Fischbach, L. Gut (2010) [Pubmed]
  6. Dual proton pump inhibitor plus amoxicillin as an empiric anti-H. pylori therapy: studies from the United States. Graham, D.Y., Javed, S.U., Keihanian, S., Abudayyeh, S., Opekun, A.R. J. Gastroenterol. (2010) [Pubmed]
  7. Efficient identification and evaluation of effective Helicobacter pylori therapies. Graham, D.Y. Clin. Gastroenterol. Hepatol. (2009) [Pubmed]
  8. African, Asian or Indian enigma, the East Asian Helicobacter pylori: facts or medical myths. Graham, D.Y., Lu, H., Yamaoka, Y. J. Dig. Dis (2009) [Pubmed]
  9. Long-term proton pump inhibitor use and gastrointestinal cancer. Graham, D.Y., Genta, R.M. Curr. Gastroenterol. Rep (2008) [Pubmed]
  10. New concepts of resistance in the treatment of Helicobacter pylori infections. Graham, D.Y., Shiotani, A. Nat. Clin. Pract. Gastroenterol. Hepatol (2008) [Pubmed]
  11. Therapy for Helicobacter pylori infection can be improved: sequential therapy and beyond. Graham, D.Y., Lu, H., Yamaoka, Y. Drugs (2008) [Pubmed]
  12. Gastric endoscopy in the 21st century: appropriate use of an invasive procedure in the era of non-invasive testing. Graham, D.Y., Kato, M., Asaka, M. Dig. Liver. Dis (2008) [Pubmed]
  13. Contemplating the future without Helicobacter pylori and the dire consequences hypothesis. Graham, D.Y., Yamaoka, Y., Malaty, H.M. Helicobacter (2007) [Pubmed]
  14. Thoughts about populations with unexpected low prevalences of Helicobacter pylori infection. Graham, D.Y., Yamaoka, Y., Malaty, H.M. Trans. R. Soc. Trop. Med. Hyg. (2007) [Pubmed]
  15. Sequential therapy using high-dose esomeprazole-amoxicillin followed by gatifloxacin for Helicobacter pylori infection. Graham, D.Y., Abudayyeh, S., El-Zimaity, H.M., Hoffman, J., Reddy, R., Opekun, A.R. Aliment. Pharmacol. Ther. (2006) [Pubmed]
  16. Visible small-intestinal mucosal injury in chronic NSAID users. Graham, D.Y., Opekun, A.R., Willingham, F.F., Qureshi, W.A. Clin. Gastroenterol. Hepatol. (2005) [Pubmed]
  17. Novel bismuth-metronidazole-tetracycline triple-layer tablet for treatment of Helicobacter pylori. Graham, D.Y., Opekun, A.R., Belson, G., El-Zimaity, H.M., Carlson, M.R. Aliment. Pharmacol. Ther. (2005) [Pubmed]
  18. Practical rapid, minimally invasive, reliable nonendoscopic method to obtain Helicobacter pylori for culture. Graham, D.Y., Kudo, M., Reddy, R., Opekun, A.R. Helicobacter (2005) [Pubmed]
  19. The time to eradicate gastric cancer is now. Graham, D.Y., Shiotani, A. Gut (2005) [Pubmed]
  20. Twice daily (mid-day and evening) quadruple therapy for H. pylori infection in the United States. Graham, D.Y., Belson, G., Abudayyeh, S., Osato, M.S., Dore, M.P., El-Zimaity, H.M. Dig. Liver. Dis (2004) [Pubmed]
  21. Challenge model for Helicobacter pylori infection in human volunteers. Graham, D.Y., Opekun, A.R., Osato, M.S., El-Zimaity, H.M., Lee, C.K., Yamaoka, Y., Qureshi, W.A., Cadoz, M., Monath, T.P. Gut (2004) [Pubmed]
  22. Is the use of COX-2 inhibitors in gastroenterology cost-effective?. Graham, D.Y., Chan, F.K. Nature Clinical Practice. Gastroenterology & Hepatology (2004) [Pubmed]
  23. Early events in proton pump inhibitor-associated exacerbation of corpus gastritis. Graham, D.Y., Opekun, A.R., Yamaoka, Y., Osato, M.S., el-Zimaity, H.M. Aliment. Pharmacol. Ther. (2003) [Pubmed]
  24. Meta-analysis: proton pump inhibitor or H2-receptor antagonist for Helicobacter pylori eradication. Graham, D.Y., Hammoud, F., El-Zimaity, H.M., Kim, J.G., Osato, M.S., El-Serag, H.B. Aliment. Pharmacol. Ther. (2003) [Pubmed]
  25. Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole. Graham, D.Y., Agrawal, N.M., Campbell, D.R., Haber, M.M., Collis, C., Lukasik, N.L., Huang, B. Arch. Intern. Med. (2002) [Pubmed]
  26. Rescue Therapy for Helicobacter pylori. Leung, W.K., Graham, D.Y. Curr. Treat. Options. Gastroenterol (2002) [Pubmed]
  27. Commentary: What remains to be done regarding transmission of Helicobacter pylori. Graham, D.Y., Malaty, H.M. Int. J. Epidemiol (2002) [Pubmed]
  28. Nitrofurantoin quadruple therapy for Helicobacter pylori infection: effect of metronidazole resistance. Graham, D.Y., Saeed, M.A., Hoffman, J., El-Zimaity, H.M., Kwon, D.H., Osato, M.S. Aliment. Pharmacol. Ther. (2001) [Pubmed]
  29. Rapid detection of anti-Helicobacter pylori IgG in urine using immunochromatography. Graham, D.Y., Reddy, S. Aliment. Pharmacol. Ther. (2001) [Pubmed]
  30. Furazolidone combination therapies for Helicobacter pylori infection in the United States. Graham, D.Y., Osato, M.S., Hoffman, J., Opekun, A.R., Anderson, S.Y., El-Zimaity, H.M. Aliment. Pharmacol. Ther. (2000) [Pubmed]
  31. Metronidazole containing quadruple therapy for infection with metronidazole resistant Helicobacter pylori: a prospective study. Graham, D.Y., Osato, M.S., Hoffman, J., Opekun, A.R., Anderson, S.Y., Kwon, D.H., El-Zimaity, H.M. Aliment. Pharmacol. Ther. (2000) [Pubmed]
  32. Therapy of Helicobacter pylori: current status and issues. Graham, D.Y. Gastroenterology (2000) [Pubmed]
  33. Accurate diagnosis of Helicobacter pylori. 13C-urea breath test. Graham, D.Y., Klein, P.D. Gastroenterol. Clin. North Am. (2000) [Pubmed]
  34. Ranitidine bismuth citrate, tetracycline, clarithromycin twice-a-day triple therapy for clarithromycin susceptible Helicobacter pylori infection. Graham, D.Y., Hoffman, J., Anderson, S.Y., Qureshi, W., Osato, M.S., El-Zimaity, H.M. Aliment. Pharmacol. Ther. (1999) [Pubmed]
  35. Alendronate gastric ulcers. Graham, D.Y., Malaty, H.M. Aliment. Pharmacol. Ther. (1999) [Pubmed]
  36. H. pylori and cagA: relationships with gastric cancer, duodenal ulcer, and reflux esophagitis and its complications. Graham, D.Y., Yamaoka, Y. Helicobacter (1998) [Pubmed]
  37. Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: a model. Graham, D.Y. Gastroenterology (1997) [Pubmed]
 
WikiGenes - Universities